MedPath

Oxford Biomedical Technologies, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)

Not Applicable
Active, not recruiting
Conditions
IBS - Irritable Bowel Syndrome
Interventions
Diagnostic Test: Leukocyte Activation Assay (LAA-MRT) / Lifestyle Eating and Performance (LEAP) program
First Posted Date
2022-01-05
Last Posted Date
2025-05-25
Lead Sponsor
Oxford Biomedical Technologies, Inc.
Target Recruit Count
60
Registration Number
NCT05178017
Locations
🇺🇸

Oxford Biomedical Technologies, Inc., Riviera Beach, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath